97P Neoadjuvant durvalumab plus gemcitabine and cisplatin (D+GemCis) versus gemcis alone for localized biliary tract cancer (BTC): Results of a randomized, multicenter, open-label, phase II trial (DEBATE)
Changhoon Yoo, Joon Oh Park, Kwang Pyo Kim, Jaewon Hyung, B-Y. Ryoo, Jung Yong Hong, Sang Hyun Shin, Tae Jun Song, Dongwook Oh, Woohyung Lee, Bong Jun Kwak, Jeong Hyun Lee, Dae Wook Hwang
Topics & Concepts
MedicineGemcitabineClinical endpointNeoadjuvant therapyInternal medicinePhases of clinical researchIntrahepatic CholangiocarcinomaSurgeryRandomized controlled trialChemotherapyGastroenterologyCancerBreast cancerCholangiocarcinoma and Gallbladder Cancer StudiesCancer Genomics and DiagnosticsGenetic factors in colorectal cancer